8 results about "Atrioventricular conduction" patented technology

Implantable medical device for stimulating a heart includes a proximal electrode pole, and first and second distal electrode poles. During operation, the device performs: a) detecting an intrinsic atrial contraction of the heart; b) detecting an intrinsic ventricular contraction of the heart; c) determining a first intrinsic atrioventricular conduction time between i) the intrinsic atrial contraction or the stimulation of the atrium and ii) the intrinsic ventricular contraction detected with the first distal electrode pole; and determining a second intrinsic atrioventricular conduction time between i) the intrinsic atrial contraction or the stimulation of the atrium and iii) the intrinsic ventricular contraction detected with the second distal electrode pole; d) setting a stimulated atrioventricular conduction time for stimulating the ventricle of the heart with the first and / or second distal electrode poles, the stimulated atrioventricular conduction time being shorter than the shorter of the first and second intrinsic atrioventricular conduction times.

Methods and systems are provided for a rate adaptive bi-ventricular fusion pacing. The methods and systems deliver a first pulse at a left ventricular (LV) lead and a second pulse at a right ventricular (RV) lead based on a paced atrio-ventricular (AV) delay. The first pulse timed to be delivered concurrently with an intrinsic ventricular conduction. The methods and systems further repeat the delivery of the first pulse and the second pulse for a predetermined number of cycles. Additionally, the methods and systems measure an intrinsic AV conduction interval, and adjust the paced AV delay based on the intrinsic AV conduction interval and a negative hysteresis delta.

An implantable system detecting electrical signals of a human or animal heart includes a processor, a memory unit, a first detection unit for atrial activity, a second detection unit for right ventricular activity and a third detection unit for left ventricular activity. The system automatically performs steps at regular intervals including detecting an intrinsic right atrial activity using the first detection unit; detecting an intrinsic right ventricular activity using the second detection unit; determining a time between the intrinsic right atrial activity and the intrinsic right ventricular activity, and storing this time as atrioventricular conduction time. Additionally or alternatively the steps include detecting an intrinsic right ventricular activity using the second detection unit; detecting an intrinsic left ventricular activity using the third detection unit; and determining a time between the intrinsic right ventricular activity and the intrinsic left ventricular activity, and storing this time as interventricular conduction time.

A pacemaker is configured to operate in an atrial synchronous ventricular pacing mode and, after expiration of a conduction check time interval, switch to an asynchronous ventricular pacing mode that includes setting a ventricular pacing interval to a base pacing rate interval. The pacemaker is further configured to determine when atrioventricular block detection criteria are satisfied during the asynchronous ventricular pacing mode and, responsive to the atrioventricular block detection criteria being satisfied, switch back to the atrial synchronous ventricular pacing mode.

A pacemaker is configured to operate in an atrial synchronous ventricular pacing mode and, after expiration of a conduction check time interval, switch to an asynchronous ventricular pacing mode that includes setting a ventricular pacing interval to a base pacing rate interval. The pacemaker is further configured to determine when atrioventricular block detection criteria are satisfied during the asynchronous ventricular pacing mode and, responsive to the atrioventricular block detection criteria being satisfied, switch back to the atrial synchronous ventricular pacing mode.

A system and method for monitoring and treating a patient with heart failure is discussed. The system may receive atrioventricular (AV) conduction characteristics at different heart rates or different patient conditions. Stimulation parameters, including stimulation timing parameters, may be stored in a memory. The system may include stimulation control circuitry configured to use the patient's AV conduction characteristics to determine a parameter update schedule indicating timings at which stimulation parameters are to be updated, and to dynamically update at least a portion of a stored set of stimulation parameters in the determined parameter update schedule. Stimulation parameters may be selected from the set of stimulation parameters for use during cardiac stimulation for a specified heart rate or heart rate range.

The invention relates to an implantable medical device for stimulating a human or animal heart that comprises a single electrode (20) comprising a proximal electrode pole (213) designed and arranged to be implanted within an atrium (2) of the heart (1) to be stimulated and a distal electrode pole (203) designed and arranged to be implanted within the septum (13) of the heart (1) to be stimulated. During operation, the implantable medical device performs the following steps: a) detecting (500), with the proximal electrode pole (213), an intrinsic atrial contraction of the heart (1) to be stimulated or stimulating (500), with the proximal electrode pole (213), the atrium (2) of the heart (1) to be stimulated; b) detecting (530), with the distal electrode pole (203), an intrinsic ventricular contraction of the heart (1) to be stimulated; c) determining (530) an intrinsic atrioventricular conduction time between i) the intrinsic atrial contraction or the stimulation of the atrium and ii) the intrinsic ventricular contraction; d) setting (550) a stimulated atrioventricular conduction time for stimulating the ventricle (3, 5) of the heart (1) to be stimulated with the distal electrode pole (203), the stimulated atrioventricular conduction time being shorter than the intrinsic atrioventricular conduction time.

The invention relates to an implantable medical device for stimulating a human or animal heart, the device comprising a single electrode (20) comprising a proximal electrode pole (213) designed and arranged to be implanted within an atrium (2) of the heart (1) to be stimulated and a distal electrode pole (203) designed and arranged to be implanted within a septum (13) of the heart (1) to be stimulated. During operation, the implantable medical device performs the following steps: a) detecting (500) an intrinsic atrial contraction of the heart (1) to be stimulated with the proximal electrode pole (213) or stimulating (500) the atrium (2) of the heart (1) to be stimulated with the proximal electrode pole (213); b) detecting (530) an intrinsic ventricular contraction of the heart (1) to be stimulated with the distal electrode pole (203); c) determining (530) an intrinsic atrioventricular conduction time between i) the intrinsic atrial contraction or the stimulation of the atrium and ii) the intrinsic ventricular contraction; d) setting (550) a stimulated atrioventricular conduction time for stimulating a ventricle (3, 5) of the heart (1) to be stimulated with the distal electrode pole (203), the stimulated atrioventricular conduction time being shorter than the intrinsic atrioventricular conduction time.